In LnCaP prostate cancer cells and in breast cancer cells SFN has caused a reduction of DNA methyltransferases expression, particularly DNMT1 and DNMT3a. This has diminished the mRNA level of DNMTs, which are associated with re-expression of certain genes [44,51,52,53,54]. The gene discussed is DNMT1; the disease is breast carcinoma.